首页> 外国专利> COMPOSITION FOR TREATING HEPATIC CANCER COMPRISING MESENCHYMAL STEM CELL TRANSFECTED WITH IL-12 EXPRESSING VECTOR AND THE TREATMENT METHODS USING THE SAME

COMPOSITION FOR TREATING HEPATIC CANCER COMPRISING MESENCHYMAL STEM CELL TRANSFECTED WITH IL-12 EXPRESSING VECTOR AND THE TREATMENT METHODS USING THE SAME

机译:包含经IL-12表达载体转化的间充质干细胞的肝癌治疗组合物及使用该方法的治疗方法

摘要

The present invention relates to a composition for treating a liver cancer and a liver cancer treatment method of a mammal. The composition includes a mesenchymal stem cell transduced as an adenovirus vector which expresses an IL-12, and is used with radiotherapy in order to increase an expression of the IL-12 from the mesenchymal stem cell. By using the composition for treating a liver cancer, which includes the mesenchymal stem cell transduced as the adenovirus vector which expresses the IL-12, with the radiotherapy, the composition of the present invention can have less side effects than using an existing chemical method by inducing a cell death effect by increasing an anticancer immune effect inside a liver cancer cell, and can increase an effect of the radiotherapy.
机译:本发明涉及用于治疗哺乳动物的肝癌的组合物和肝癌的治疗方法。该组合物包括作为表达IL-12的腺病毒载体转导的间充质干细胞,并与放射疗法一起使用以增加来自间充质干细胞的IL-12的表达。通过使用放射治疗将包含作为表达IL-12的腺病毒载体转导的间充质干细胞转导的间充质干细胞用于治疗肝癌的组合物,与使用现有化学方法相比,本发明的组合物具有更少的副作用。通过增加肝癌细胞内部的抗癌免疫作用来诱导细胞死亡作用,并且可以增加放射疗法的作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号